Rehab Exoskeletons
ReWalk, Ekso, Cyberdyne HAL and clinical evidence.
9 articles
An evidence-based assessment of the three dominant rehabilitation exoskeleton manufacturers—ReWalk Robotics, Ekso Bionics, and Cyberdyne—focusing on shipping hardware, clinical efficacy, and the current state of availability within the Indian healthcare landscape.
An analysis of shipping medical exoskeletons including ReWalk, Ekso Bionics, and Cyberdyne HAL. This report evaluates clinical evidence, regulatory status in India, and hardware availability without speculative hype.
An analysis of ReWalk, Ekso, and Cyberdyne HAL units focusing on deployed hardware, clinical outcomes, and India-specific availability and pricing.
A grounded review of lower-limb exoskeletons from ReWalk, Ekso, and Cyberdyne. Focus on shipping hardware, regulatory status, and Indian market entry barriers.
An evidence-based review of shipping rehabilitation exoskeletons including ReWalk, Ekso Bionics, and Cyberdyne HAL, evaluating clinical efficacy, hardware maturity, and India market entry barriers.
ReWalk, Ekso Bionics, and Cyberdyne HAL move beyond concept art. This review grades hardware availability, pilot deployments, and clinical evidence for medical-grade exoskeletons, with a specific focus on Indian market entry, CDSCO regulations, and landed cost estimates.
RobotWale covers CorTec Brain-Computer Interface Gets FDA Breakthrough Tag — what it means for the Indian robotics ecosystem, pricing, specs and deployment outlook.
A practical look at Rehab exoskeletons: what the clinical evidence shows as part of our Rehab Exoskeletons coverage in Healthcare & Assistive. What the machines actually do, how much they cost, and what Indian buyers and builders should know.
A practical look at ReWalk, Ekso and the exoskeleton ecosystem as part of our Rehab Exoskeletons coverage in Healthcare & Assistive. What the machines actually do, how much they cost, and what Indian buyers and builders should know.